About Triopsy
Triopsy is a company based in Aurora (United States) founded in 2012. Triopsy has raised $4.14 million across 7 funding rounds from investors including Colorado Office of Economic Development and International Trade. Triopsy offers products and services including Triopsy Biopsy System, Specimen Transport, and Renaissance LIS Software. Triopsy operates in a competitive market with competitors including Exact Imaging, KOELIS, Exact Imaging, Clariflow and Focal Healthcare, among others.
- Headquarter Aurora, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Triopsy Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.14 M (USD)
in 7 rounds
-
Latest Funding Round
$100 K (USD), Seed
Jan 10, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Triopsy
Triopsy offers a comprehensive portfolio of products and services, including Triopsy Biopsy System, Specimen Transport, and Renaissance LIS Software.
Captures more tissue for accurate prostate cancer diagnosis and reduces errors.
Preserves and transports biopsy samples intact to prevent misdiagnosis.
Manages biopsy samples and generates customized pathology reports efficiently.
Funding Insights of Triopsy
Triopsy has successfully raised a total of $4.14M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $100 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Triopsy
Triopsy has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Colorado Office of Economic Development and International Trade.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Economic development and international trade are facilitated for Colorado businesses.
|
Locked | Locked | Locked |
Investor details for Triopsy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Triopsy
Investment portfolio details for Triopsy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Triopsy
Detailed financials for Triopsy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Triopsy Comparisons
Peer comparison for Triopsy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Triopsy
Triopsy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exact Imaging, KOELIS, Exact Imaging, Clariflow and Focal Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Micro-ultrasound devices for prostate imaging and biopsies are developed.
|
|
| Locked | Locked | Locked |
MRI/ultrasound fusion biopsy systems for prostate care are developed.
|
|
| Locked | Locked | Locked |
Prostate cancer imaging is enabled by micro-ultrasound technology.
|
|
| Locked | Locked | Locked |
Provides DIY test kits for benign prostatic hyperplasia (BPH).
|
|
| Locked | Locked | Locked |
MRI/TRUS fusion systems for prostate biopsy guidance are developed.
|
Detailed competitors of Triopsy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Triopsy
Complete news archive for Triopsy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triopsy
Triopsy was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Triopsy is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
David G Bostwick is the current CEO of Triopsy.
Triopsy is a funded company, having raised a total of $4.14M across 7 funding rounds to date.
Triopsy was founded in 2012 and is headquartered in Aurora, United States. Operations focus on the medical device sector, where a system integrating biopsy and pathology technologies is utilized for identifying tumor locations, disease types, stages, and genomic profiles. This aids in diagnosis and treatment planning for prostate cancer, supporting pathways to personalized medicine.
Triopsy's top competitors include KOELIS, Exact Imaging and Exact Imaging.
Triopsy offers Triopsy Biopsy System, Specimen Transport, and Renaissance LIS Software.
Triopsy has 1 investor. Key investors include Colorado Office of Economic Development and International Trade.